Rockefeller Capital Management’s CONMED CNMD Stock Holding History

Rockefeller Capital Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$46.3K	Buy	1,414 +26	+2%	+$936	﹤0.01%	3407
2026 Q1	$49.1K	Buy	1,388 +345	+33%	+$14K	﹤0.01%	3287
2025 Q4	$42.4K	Buy	1,043 +341	+49%	+$14.8K	﹤0.01%	3145
2025 Q3	$33K	Buy	+702	New	+$36.4K	﹤0.01%	3106
2023 Q1	–	Sell	-44	Closed	-$3K	–	2329
2022 Q4	$3K	Sell	44 -44	-50%	-$3.65K	﹤0.01%	3443
2022 Q3	$6K	Sell	88 -29	-25%	-$2.74K	﹤0.01%	3265
2022 Q2	$10K	Buy	117 +23	+24%	+$2.76K	﹤0.01%	3107
2022 Q1	$13K	Sell	94 -66	-41%	-$9.22K	﹤0.01%	2906
2021 Q4	$21K	Buy	160 +125	+357%	+$17.7K	﹤0.01%	2623
2021 Q3	$3K	Buy	35 +20	+133%	+$2.62K	﹤0.01%	3318
2021 Q2	$2K	Buy	15 +6	+67%	+$821	﹤0.01%	3231
2021 Q1	$1K	Buy	+9	New	+$1.08K	﹤0.01%	3164
2019 Q3	–	Sell	-129	Closed	-$11K	–	1926
2019 Q2	$11K	Buy	+129	New	+$10.6K	﹤0.01%	1197

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

SEI Investments Oaks, Pennsylvania $113B AUM 34.64% 1-Year Est. Return

ICM

Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return

Rockefeller Capital Management's CNMD Position: Q2 2026 in Review

Rockefeller Capital Management increased its CONMED (CNMD) stake by 1.9% in Q2 2026, buying an estimated $936 and bringing the position to 1,414 shares worth $46.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3407.

Rockefeller Capital Management first reported a position in CNMD in Q2 2019 and has held it in 13 quarters since. The position peaked at $49.1K in Q1 2026. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

Rockefeller Capital Management held 1,414 shares of CONMED worth $46.3K as of Q2 2026.
Rockefeller Capital Management bought 26 CONMED shares in Q2 2026, an estimated $936.
CONMED made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3407 holding.
Rockefeller Capital Management first reported a position in CONMED in Q2 2019 and has held it in 13 quarters since.
Rockefeller Capital Management's CONMED position peaked at $49.1K in Q1 2026.
246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.